AULRX | RGEBX | AULRX / RGEBX | |
Total Expense Ratio | 1.37 | 1.09 | 126% |
Annual Report Gross Expense Ratio | 1.42 | 1.09 | 130% |
Fund Existence | 22 years | 11 years | - |
Gain YTD | 11.970 | 18.561 | 64% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 250 | 1,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 27.4B | 343B | 8% |
Annual Yield % from dividends | 0.00 | 0.00 | - |
Returns for 1 year | 15.09 | 14.27 | 106% |
Returns for 3 years | 69.60 | 72.01 | 97% |
Returns for 5 years | 40.65 | 39.33 | 103% |
Returns for 10 years | 162.24 | 95.24 | 170% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
DFCF | 42.88 | 0.08 | +0.19% |
Dimensional Core Fixed Income ETF | |||
UCIB | 27.43 | 0.04 | +0.13% |
UBS ETRACS BgCstMtCdy(CMCI)TtlRetETNSerB | |||
SIHY | 46.13 | 0.01 | +0.02% |
Harbor Scientific Alpha High-Yield ETF | |||
THNR | 24.82 | N/A | N/A |
Amplify Weight Loss Drug & Treatment ETF | |||
FDRR | 58.92 | -0.25 | -0.43% |
Fidelity Dividend ETF for Rising Rates |